Squarepoint’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.98M Sell
81,498
-155,335
-66% -$11.4M 0.01% 727
2025
Q1
$27.1M Buy
+236,833
New +$27.1M 0.03% 293
2024
Q4
Hold
0
2829
2024
Q3
Hold
0
2608
2024
Q2
Sell
-44,007
Closed -$1.11M 2560
2024
Q1
$1.11M Sell
44,007
-30,504
-41% -$768K ﹤0.01% 1304
2023
Q4
$2.42M Buy
74,511
+16,564
+29% +$538K ﹤0.01% 947
2023
Q3
$1.58M Sell
57,947
-22,813
-28% -$622K ﹤0.01% 1085
2023
Q2
$1.8M Buy
+80,760
New +$1.8M 0.01% 942
2023
Q1
Sell
-22,627
Closed -$460K 2346
2022
Q4
$460K Sell
22,627
-10,957
-33% -$223K ﹤0.01% 1489
2022
Q3
$861K Sell
33,584
-28,261
-46% -$725K ﹤0.01% 1145
2022
Q2
$1.47M Sell
61,845
-50,849
-45% -$1.21M 0.01% 880
2022
Q1
$2.54M Buy
112,694
+40,799
+57% +$919K 0.01% 694
2021
Q4
$1.42M Buy
71,895
+59,285
+470% +$1.17M ﹤0.01% 1042
2021
Q3
$248K Buy
+12,610
New +$248K ﹤0.01% 1713
2021
Q1
Sell
-63,448
Closed -$1.66M 2634
2020
Q4
$1.66M Buy
+63,448
New +$1.66M 0.01% 826
2020
Q3
Sell
-18,113
Closed -$305K 2370
2020
Q2
$305K Sell
18,113
-46,913
-72% -$790K ﹤0.01% 1552
2020
Q1
$773K Buy
+65,026
New +$773K 0.02% 830
2019
Q4
Sell
-24,697
Closed -$349K 2416
2019
Q3
$349K Sell
24,697
-148,674
-86% -$2.1M ﹤0.01% 1743
2019
Q2
$1.93M Buy
173,371
+29,788
+21% +$332K 0.02% 854
2019
Q1
$1.69M Buy
143,583
+32,044
+29% +$376K 0.02% 848
2018
Q4
$1.49M Buy
+111,539
New +$1.49M 0.02% 767
2018
Q3
Sell
-57,997
Closed -$912K 2005
2018
Q2
$912K Sell
57,997
-269,594
-82% -$4.24M 0.01% 930
2018
Q1
$5.39M Buy
327,591
+297,864
+1,002% +$4.9M 0.09% 294
2017
Q4
$537K Buy
29,727
+4,166
+16% +$75.3K 0.01% 1156
2017
Q3
$493K Sell
25,561
-13,939
-35% -$269K 0.01% 969
2017
Q2
$466K Buy
39,500
+23,984
+155% +$283K 0.01% 974
2017
Q1
$170K Sell
15,516
-25,584
-62% -$280K ﹤0.01% 1315
2016
Q4
$298K Buy
+41,100
New +$298K 0.01% 1154